EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Central Obesity in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Prevalence, Clinical Correlates, and In-Hospital Outcomes

Rajesh Kumar, Lajpat Rai, Syed Ahsan Raza, Bilal Akhtar, Jaghat Ram, Muhammad Owais Shahid, Shaheer Khan Muhammad, Neelam Anees, Ali Hyder, Sumaira Fareed Khan, Haya Jawaid, Nasir Yaqoob, Bisma Jalil, Shitba Naeem, Abdul Fatah Tunio, Abiha Urooj, Jamil Ur Rahman, Rabia Adab, Uroosa Safdar

Pakistan Heart Journal · 2026-10-31 · 59 (5) · 1305-1312

DOI: 10.47144/phj.v59i5.3161 ↗
AbstractBibliografische Angaben

Abstract

Objectives: Central obesity (CO), characterized by excess abdominal adiposity, is a well-established cardiovascular risk factor. However, its specific clinical implications in patients presenting with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) remain insufficiently defined. This study aimed to determine the prevalence of CO, evaluate its associated clinical characteristics, and assess its impact on in-hospital outcomes in this high-risk population. Methodology: This prospective cohort study included patients presenting with STEMI who underwent primary PCI. Central obesity was defined using waist circumference thresholds of ≥90 cm in men and ≥80 cm in women [10]. Patients were followed throughout their hospital stay for the occurrence of adverse clinical outcomes, including mortality and procedural complications. Results: A total of 1,099 patients were enrolled, of whom 78.0% (n=857) were male, with a mean age of 54.66 ± 10.9 years. Central obesity was present in 68.7% (n=755) of patients. The prevalence of CO was comparable between females and males (73.6% vs. 67.3%; p=0.065). Patients with CO had a significantly higher prevalence of general obesity (72.7% vs. 38.4%; p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →